IBIO · Company research

iBio, Inc. Common Stock (IBIO): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

17records availableHealthcare

Stock News & Events data

Database-backed records only

17 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
At $0.78 per share, 38,000 options go to iBio (IBIO) director Elizabeth Stoner. - Stock TitanAt $0.78 per share, 38,000 options go to iBio (IBIO) director Elizabeth Stoner. Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
A director receives 38,000 iBio (IBIO) stock options with a $0.78 exercise price. - Stock TitanA director receives 38,000 iBio (IBIO) stock options with a $0.78 exercise price. Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
iBio, Inc. Stock 12‑Month Price Target Raised to $5.6, Implies 509% Upside - TradingViewiBio, Inc. Stock 12‑Month Price Target Raised to $5.6, Implies 509% Upside TradingViewView source ↗TradingViewOct 9, 2026neutral00.6
iBio, Inc. Stock 12‑Month Price Target Cut to $5.53, Implies 447% Upside - TradingViewiBio, Inc. Stock 12‑Month Price Target Cut to $5.53, Implies 447% Upside TradingViewView source ↗TradingViewOct 8, 2026neutral00.6
iBio, Inc. (IBIO) Presents at 2026 EASD Annual Meeting - Slideshow (NASDAQ:IBIO) 2026-10-07 - Seeking AlphaiBio, Inc. (IBIO) Presents at 2026 EASD Annual Meeting - Slideshow (NASDAQ:IBIO) 2026-10-07 Seeking AlphaView source ↗Seeking AlphaOct 7, 2026neutral00.6
iBio (Nasdaq:IBIO) - Stock Analysis - Simply Wall StreetiBio (Nasdaq:IBIO) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetOct 7, 2026neutral00.6
iBio, Inc. (NASDAQ:IBIO) Stock Now Rated "Buy" by Wall Street Brokerages - MarketBeatiBio, Inc. (NASDAQ:IBIO) Stock Now Rated "Buy" by Wall Street Brokerages MarketBeatView source ↗MarketBeatSep 28, 2026neutral00.6
iBio stock initiated at buy by H.C. Wainwright with $7 target - Investing.comiBio stock initiated at buy by H.C. Wainwright with $7 target Investing.comView source ↗Investing.comSep 17, 2026neutral00.6
iBio Reports Fiscal 2026 Financial Results and Corporate Update Highlighting Clinical and Pipeline Progress - Quiver QuantitativeiBio Reports Fiscal 2026 Financial Results and Corporate Update Highlighting Clinical and Pipeline Progress Quiver QuantitativeView source ↗Quiver QuantitativeAug 28, 2026neutral00.6
Affinity Asset Advisors (IBIO) discloses 5.07M-share, 9.99% stake in iBio - Stock TitanAffinity Asset Advisors (IBIO) discloses 5.07M-share, 9.99% stake in iBio Stock TitanView source ↗Stock TitanAug 13, 2026neutral00.6
$IBIO stock is up 13% today. Here's what we see in our data. - Quiver Quantitative$IBIO stock is up 13% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJul 1, 2026neutral00.6
IBIO Forecast — Price Target — Prediction for 2027 - TradingViewIBIO Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Could iBio (IBIO) Be an Underrated Obesity Stock? - Yahoo FinanceCould iBio (IBIO) Be an Underrated Obesity Stock? Yahoo FinanceView source ↗Yahoo FinanceJun 11, 2026neutral00.6
IBIO - FinvizIBIO FinvizView source ↗FinvizMay 28, 2026neutral00.6
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewswireiBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update GlobeNewswireView source ↗GlobeNewswireMay 12, 2026neutral00.6
iBio, Inc. Common Stock (IBIO) Stock Price: Oct 8 Close $0.9200 - GotradeiBio, Inc. Common Stock (IBIO) Stock Price: Oct 8 Close $0.9200 GotradeView source ↗GotradeMar 1, 2026neutral00.6
IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement - StocktwitsIBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement StocktwitsView source ↗StocktwitsJan 9, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.